Results 11 to 20 of about 3,018,020 (304)

Vaccine adjuvants: mechanisms and platforms

open access: yesSignal Transduction and Targeted Therapy, 2023
Abstract Adjuvants are indispensable components of vaccines. Despite being widely used in vaccines, their action mechanisms are not yet clear. With a greater understanding of the mechanisms by which the innate immune response controls the antigen-specific response, the adjuvants’ action mechanisms are beginning to be elucidated ...
Tingmei Zhao   +6 more
openaire   +3 more sources

Virus-like Particle Vaccines and Platforms for Vaccine Development

open access: yesViruses, 2023
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human papillomavirus, and hepatitis E virus—has been approved; they are very efficacious and offer long-lasting immune responses.
Milad Kheirvari   +2 more
openaire   +3 more sources

Subviral particle as vaccine and vaccine platform

open access: yesCurrent Opinion in Virology, 2014
Recombinant subvirual particles retain similar antigenic features of their authentic viral capsids and thus have been applied as nonreplicating subunit vaccines against viral infection and illness. Additionally, the self-assembled, polyvalent subviral particles are excellent platforms to display foreign antigens for immune enhancement for vaccine ...
Tan, Ming, Jiang, Xi
openaire   +2 more sources

The distribution of fake Australian vaccine digital certificates on an alt-tech platform

open access: yes, 2022
This paper provides the first exploration of the online distribution of fake Australian COVID-19 vaccine certificates. Drawing on a collection of 2589 posts between five distributors and their community members on the alt-tech platform Gab, this study ...
Childs, Andrew, Andrew Childs
core   +1 more source

Outer Membrane Vesicle Vaccine Platforms

open access: yesBioDrugs, 2023
Outer membrane vesicles (OMVs) are spontaneously released by many gram-negative bacteria during their growth and constitute an important virulence factor for bacteria, helping them to survive through harsh environmental conditions. Native OMVs, naturally-released from bacteria, are produced at a level too low for vaccine manufacturing, requiring ...
Micoli, Francesca   +2 more
openaire   +2 more sources

A novel malaria vaccine candidate antigen expressed in Tetrahymena thermophila [PDF]

open access: yes, 2014
Development of effective malaria vaccines is hampered by the problem of producing correctly folded Plasmodium proteins for use as vaccine components.
David R. Cavanagh   +27 more
core   +2 more sources

Effectiveness and safety of injectable human papilloma virus vaccine administered as eyedrops

open access: yes, 2023
Mucosal vaccines have the advantages of ease of administration and the induction of strong mucosal immunity and a systemic immune response. Recently, the eye mucosa has been shown to be an effective and safe alternative vaccination route against ...
윤상철, 서경률, 이지혜
core   +1 more source

Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom [PDF]

open access: yes, 2013
An analysis was undertaken to measure age-specific vaccine effectiveness (VE) of 2010/11 trivalent seasonal influenza vaccine (TIV) and monovalent 2009 pandemic influenza vaccine (PIV) administered in 2009/2010.
Ellis, J.   +23 more
core   +4 more sources

Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to ΔVP8* protein from rotavirus

open access: yes, 2021
Conjugation of carbohydrate antigens with a carrier protein is a clinically proven strategy to overcome the poor immunogenicity of bacterial polysaccharide.
조상래   +8 more
core   +1 more source

Lipid-Polyglutamate Nanoparticle Vaccine Platform

open access: yesACS Applied Materials & Interfaces, 2021
Peptide-based subunit vaccines are attractive in view of personalized cancer vaccination with neo-antigens, as well as for the design of the newest generation of vaccines against infectious diseases. Key to mounting robust antigen-specific immunity is delivery of antigen to antigen-presenting (innate immune) cells in lymphoid tissue with concomitant ...
Van Lysebetten, Dorien   +17 more
openaire   +7 more sources

Home - About - Disclaimer - Privacy